• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本声称具有特定功能的食品系统评价的质量:消费者厅验证报告的前后对比评估。

Quality of Systematic Reviews of the Foods with Function Claims in Japan: Comparative Before- and After-Evaluation of Verification Reports by the Consumer Affairs Agency.

机构信息

Faculty of Regional Environment Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.

Tokyo Ariake Medical and Health Sciences University, 2-9-1 Ariake, Kouto-ku, Tokyo 135-0063, Japan.

出版信息

Nutrients. 2019 Jul 12;11(7):1583. doi: 10.3390/nu11071583.

DOI:10.3390/nu11071583
PMID:31336978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6682984/
Abstract

In Japan, a new type of foods with health claims, called Foods with Function Claims (FFC), was introduced in April 2015 in order to make more products available that are clearly labeled with certain health functions. Regarding substantiating product effectiveness, scientific evidence for the proposed function claims must be explained by systematic reviews (SRs), but the quality of SRs was not clear. The objectives of this review were to assess the quality of SRs based on the FFC registered on the Consumer Affairs Agency (CAA) website in Japan, and to determine whether the CAA's verification report in 2016 was associated with improvement in the quality of SRs. We evaluated the reporting quality of each SR by the AMSTAR checklist on methodological quality. We searched the database from 1 April to 31 October 2015 as the before-SR and from 1 July 2017 to 31 January 2018 as the after-SR. Among the 104 SRs reviewed, 96 final products were included: 51 (53.1%) were supplements, 42 (43.8%) were processed foods without supplements, and 3 (3.1%) were fresh foods. Of the 104 SRs, 92 (88.5%) were qualitative reviews (i.e., without meta-analysis) and 12 (11.5%) performed a meta-analysis. The average quality score of before-SRs and after-SRs was 6.2 ± 1.8 and 5.0 ± 1.9, respectively, a statistically significant decrease ( < 0.001). Overall, the methodology and reporting quality of after-SRs based on the FFC were poorer than those of before-SRs. In particular, there were very poor descriptions and/or implementations of study selection and data extraction, search strategy, evaluation methods for risk of bias, assessment of publication bias, and formulating conclusions based on methodological rigor and scientific quality of the included studies.

摘要

在日本,为了推出更多明确标注特定健康功能的产品,2015 年 4 月引入了一种新型具有保健功能声称的食品,称为“特定保健用食品”(FFC)。关于证实产品功效,必须通过系统评价(SR)来解释拟议功能声称的科学证据,但 SR 的质量并不明确。本次审查的目的是根据日本消费者事务局(CAA)网站上注册的 FFC 评估 SR 的质量,并确定 2016 年 CAA 的验证报告是否与 SR 质量的提高有关。我们使用 AMSTAR 清单评估了每个 SR 的报告质量,以评估方法质量。我们从 2015 年 4 月 1 日至 10 月 31 日作为 SR 前检索数据库,从 2017 年 7 月 1 日至 2018 年 1 月 31 日作为 SR 后检索数据库。在审查的 104 篇 SR 中,有 96 项最终产品被纳入:51 项(53.1%)为补充剂,42 项(43.8%)为无补充剂的加工食品,3 项(3.1%)为新鲜食品。在 104 篇 SR 中,92 篇(88.5%)为定性综述(即无荟萃分析),12 篇(11.5%)进行了荟萃分析。SR 前和 SR 后的平均质量评分为 6.2±1.8 和 5.0±1.9,有统计学显著下降(<0.001)。总体而言,基于 FFC 的 SR 后方法学和报告质量不如 SR 前。特别是,研究选择和数据提取、搜索策略、偏倚风险评估方法、发表偏倚评估以及基于纳入研究的方法严谨性和科学质量制定结论的描述和/或实施都非常差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd9/6682984/48e338364f07/nutrients-11-01583-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd9/6682984/ff5b6190e7e9/nutrients-11-01583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd9/6682984/48e338364f07/nutrients-11-01583-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd9/6682984/ff5b6190e7e9/nutrients-11-01583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fd9/6682984/48e338364f07/nutrients-11-01583-g002.jpg

相似文献

1
Quality of Systematic Reviews of the Foods with Function Claims in Japan: Comparative Before- and After-Evaluation of Verification Reports by the Consumer Affairs Agency.日本声称具有特定功能的食品系统评价的质量:消费者厅验证报告的前后对比评估。
Nutrients. 2019 Jul 12;11(7):1583. doi: 10.3390/nu11071583.
2
Quality of systematic reviews of the Foods with Function Claims registered at the Consumer Affairs Agency Web site in Japan: a prospective systematic review.日本消费者事务局网站注册的具有功能声称食品的系统评价质量:一项前瞻性系统评价。
Nutr Res. 2017 Apr;40:21-31. doi: 10.1016/j.nutres.2017.02.008. Epub 2017 Feb 21.
3
A Cross-Sectional Study Based on Forty Systematic Reviews of Foods with Function Claims (FFC) in Japan: Quality Assessment Using AMSTAR 2.基于日本 40 项具有功能声称的食品(FFC)的系统评价的横断面研究:使用 AMSTAR 2 进行质量评估。
Nutrients. 2023 Apr 24;15(9):2047. doi: 10.3390/nu15092047.
4
[A Study on the Scientific Reliability of Notification Data in the Foods with Function Claims].[具有功能声称食品中通报数据的科学可靠性研究]
Shokuhin Eiseigaku Zasshi. 2024;65(2):31-39. doi: 10.3358/shokueishi.65.31.
5
Comparison of methodological quality rating of systematic reviews on neuropathic pain using AMSTAR and R-AMSTAR.使用 AMSTAR 和 R-AMSTAR 比较神经病理性疼痛系统评价方法学质量评分。
BMC Med Res Methodol. 2018 May 8;18(1):37. doi: 10.1186/s12874-018-0493-y.
6
Methodological quality of systematic reviews on treatments for depression: a cross-sectional study.系统评价治疗抑郁症方法学质量的横断面研究。
Epidemiol Psychiatr Sci. 2018 Dec;27(6):619-627. doi: 10.1017/S2045796017000208. Epub 2017 May 2.
7
Reporting and Methodological Quality of Systematic Reviews and Meta-Analyses of Nursing Interventions in Patients With Alzheimer's Disease: General Implications of the Findings.阿尔茨海默病患者护理干预的系统评价和荟萃分析的报告和方法学质量:研究结果的普遍意义。
J Nurs Scholarsh. 2019 May;51(3):308-316. doi: 10.1111/jnu.12462. Epub 2019 Feb 25.
8
[Current Status and Issues on the Foods with Function Claims System in Japan: Evidence of Functionality of the Foods].[日本具有功能声称食品制度的现状与问题:食品功能的证据]
Yakugaku Zasshi. 2023 Nov 1;143(11):931-940. doi: 10.1248/yakushi.23-00121. Epub 2023 Aug 10.
9
Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023-2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials.2023-2024 年日本具有功能声称的食品临床试验报告的研究质量:基于评估随机试验偏倚风险的修订工具进行的评估。
Nutrients. 2024 Aug 17;16(16):2744. doi: 10.3390/nu16162744.
10
Abstract analysis method facilitates filtering low-methodological quality and high-bias risk systematic reviews on psoriasis interventions.摘要分析方法有助于筛选银屑病干预措施中方法学质量低和偏倚风险高的系统评价。
BMC Med Res Methodol. 2017 Dec 29;17(1):180. doi: 10.1186/s12874-017-0460-z.

引用本文的文献

1
Prebiotics in food and dietary supplements: a roadmap to EU health claims.食品和膳食补充剂中的益生元:通往欧盟健康声称的路线图。
Gut Microbes. 2024 Jan-Dec;16(1):2428848. doi: 10.1080/19490976.2024.2428848. Epub 2024 Nov 15.
2
Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023-2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials.2023-2024 年日本具有功能声称的食品临床试验报告的研究质量:基于评估随机试验偏倚风险的修订工具进行的评估。
Nutrients. 2024 Aug 17;16(16):2744. doi: 10.3390/nu16162744.
3
Trends and current food safety regulations and policies for functional foods and beverages containing botanicals.

本文引用的文献

1
Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability.系统评价中的质量评估与偏倚风险:AMSTAR 和 ROBIS 具有相似的可靠性,但在结构和适用性上有所不同。
J Clin Epidemiol. 2018 Jul;99:24-32. doi: 10.1016/j.jclinepi.2018.02.024. Epub 2018 Mar 8.
2
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.AMSTAR 2:一种用于系统评价的关键评估工具,该系统评价包括医疗保健干预措施的随机或非随机研究,或两者皆有。
BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008.
3
含植物成分的功能性食品和饮料的趋势及现行食品安全法规和政策。
J Food Drug Anal. 2024 Jun 15;32(2):112-139. doi: 10.38212/2224-6614.3499.
4
Incidents and Potential Adverse Health Effects of Serious Food Fraud Cases Originated in Asia.源自亚洲的严重食品欺诈案件的事件及潜在不良健康影响。
Foods. 2023 Sep 22;12(19):3522. doi: 10.3390/foods12193522.
5
A Cross-Sectional Study Based on Forty Systematic Reviews of Foods with Function Claims (FFC) in Japan: Quality Assessment Using AMSTAR 2.基于日本 40 项具有功能声称的食品(FFC)的系统评价的横断面研究:使用 AMSTAR 2 进行质量评估。
Nutrients. 2023 Apr 24;15(9):2047. doi: 10.3390/nu15092047.
6
Optimizing the Relationship between Regulation and Innovation in Dietary Supplements: A Case Study of Food with Function Claims in Japan.优化膳食补充剂的监管与创新关系:以日本具有功能声称的食品为例。
Nutrients. 2023 Jan 16;15(2):476. doi: 10.3390/nu15020476.
7
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders.溶血磷脂:神经退行性疾病的潜在候选药物
Biomedicines. 2022 Dec 3;10(12):3126. doi: 10.3390/biomedicines10123126.
8
Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports.日本具有功能声称(FFC)的食品临床试验方案的依从性:临床试验注册与已发表报告的一致性。
Nutrients. 2021 Dec 25;14(1):81. doi: 10.3390/nu14010081.
9
A review of antidiabetic active thiosugar sulfoniums, salacinol and neokotalanol, from plants of the genus Salacia.综述来源于 Salacia 属植物的具有抗糖尿病活性的硫代糖脎磺酸酯、柳皮苷和新诃醇。
J Nat Med. 2021 Jun;75(3):449-466. doi: 10.1007/s11418-021-01522-0. Epub 2021 Apr 26.
Quality of systematic reviews of the Foods with Function Claims registered at the Consumer Affairs Agency Web site in Japan: a prospective systematic review.
日本消费者事务局网站注册的具有功能声称食品的系统评价质量:一项前瞻性系统评价。
Nutr Res. 2017 Apr;40:21-31. doi: 10.1016/j.nutres.2017.02.008. Epub 2017 Feb 21.
4
Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.生物医学研究系统评价的流行病学及报告特征:一项横断面研究
PLoS Med. 2016 May 24;13(5):e1002028. doi: 10.1371/journal.pmed.1002028. eCollection 2016 May.
5
Countries' Biomedical Publications and Attraction Scores. A PubMed-based assessment.各国的生物医学出版物及吸引力得分。基于PubMed的评估。
F1000Res. 2014 Dec 1;3:292. doi: 10.12688/f1000research.5775.2. eCollection 2014.
6
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.PRISMA 扩展声明用于报告包含健康保健干预措施网络荟萃分析的系统评价:清单和说明。
Ann Intern Med. 2015 Jun 2;162(11):777-84. doi: 10.7326/M14-2385.
7
Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties.系统评价发现 AMSTAR 具有良好的测量特性,但 R(修订)-AMSTAR 则不然。
J Clin Epidemiol. 2015 May;68(5):574-83. doi: 10.1016/j.jclinepi.2014.12.009. Epub 2014 Dec 30.
8
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.系统评价和荟萃分析议定书的首选报告项目(PRISMA-P)2015:详细说明和解释。
BMJ. 2015 Jan 2;350:g7647. doi: 10.1136/bmj.g7647.
9
Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework.定义发表偏倚:对高引文章进行系统评价的方案及新框架的提出。
Syst Rev. 2013 May 21;2:34. doi: 10.1186/2046-4053-2-34.
10
SPIRIT 2013 statement: defining standard protocol items for clinical trials.SPIRIT 2013 声明:定义临床试验的标准议定书项目。
Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.